跳至主要内容
临床试验/NCT07084454
NCT07084454Enrolling By Invitation3 期

Geriatric Oncology Care in Brazil: Remote Geriatric Assessment-Driven Interventions With Supportive Care (The GAIN-S Trial in Brazil)

Cristiane Decat Bergerot, PhD2 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2024年12月6日最近更新:
适应症

试验速览

阶段
3 期
状态
Enrolling By Invitation
发起方
入组人数
350
试验地点
2
主要终点
Change in Physical Function (Activities of Daily Living - ADL) Score

研究概览

简要总结

The goal of this clinical trial is to determine whether a telehealth-delivered, geriatric assessment-guided supportive care program (GAIN-S) can improve health outcomes in older adults (age 65 and above) with solid tumors who are starting a new cancer treatment in Brazil. The main questions it aims to answer are:

  • Does GAIN-S improve physical function, as measured by activities of daily living (ADL), after three months?
  • Does GAIN-S reduce symptoms of depression and improve quality of life after three months?

Researchers will compare patients receiving the GAIN-S intervention to those receiving standard care to see if the intervention leads to better physical function, fewer symptoms of depression, and improved quality of life.

Participants will:

  • Complete a geriatric assessment (CARG-GA) before and after treatment.
  • Be randomized to either standard care or the GAIN-S intervention.
  • If assigned to GAIN-S, receive tailored supportive care via telehealth, which may include consultations with a psychologist, psychiatrist, nutritionist, geriatrician, exercise physiologist, or other specialists based on their needs.

详细描述

This is a multicenter, randomized controlled trial evaluating the effectiveness of a telehealth-delivered, geriatric assessment-guided intervention (GAIN-S) in improving health outcomes for older adults with solid tumors who are initiating a new systemic cancer therapy (chemotherapy, immune checkpoint inhibitors, and/or tyrosine kinase inhibitors) in Brazil.

The intervention is adapted from the Geriatric Assessment and Intervention Network (GAIN) model and integrates multidisciplinary supportive care services delivered remotely. The study is conducted across 14 oncology practices, including both private and public institutions, located in the Midwest, South, Southwest, and North regions of Brazil.

A total of 350 participants aged 65 years and older will be enrolled and randomized 1:1 to either the GAIN-S intervention or standard of care (SOC). All participants will complete a validated geriatric assessment (CARG-GA) at baseline and again at 3 months. The CARG-GA evaluates functional status, comorbidities, psychological well-being, nutrition, cognitive status, social support, and fall risk.

In the intervention arm (GAIN-S), patients will receive a tailored set of supportive care services based on their GA results. The multidisciplinary team-consisting of a medical oncologist, geriatrician, psychologist, psychiatrist, nutritionist, and exercise physiologist-will review the GA findings and deliver recommendations via telehealth (e.g., video calls or phone). Patients may receive one or more remote consultations from team members depending on their individual needs.

In the SOC arm, GA results will be shared with the treating oncologist, but no structured intervention will be implemented unless a critical issue is identified (e.g., severe depression or cognitive impairment), in which case referrals may be made.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

盲法说明

This is an open-label trial because:

  • Participants know if they are receiving the GAIN-S intervention.
  • The care providers and multidisciplinary team also know which arm the participant is in.
  • Masking is not feasible due to the nature of the intervention (telehealth and tailored supportive care).

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 65 years or older at time of enrollment
  • Diagnosed with a solid tumor cancer of any stage
  • Scheduled to start a new systemic cancer therapy (chemotherapy, immune checkpoint inhibitors, and/or tyrosine kinase inhibitors)
  • Able to provide written informed consent
  • Physician approval for participation

排除标准

  • Inability or unwillingness to comply with study procedures, including telehealth visits
  • Cognitive or other impairments precluding participation as determined by the investigator
  • Any condition that, in the investigator's opinion, would make the patient unsuitable for the study or interfere with study assessments

结局指标

主要结局

Change in Physical Function (Activities of Daily Living - ADL) Score

时间窗: Baseline to 3 months after treatment initiation

Physical function will be assessed by measuring changes in the Activities of Daily Living (ADL) score using the patient-reported portion of the CARG-GA. The primary objective is to determine if the GAIN-S intervention improves physical function compared to standard care.

Change in Physical Function (Activities of Daily Living - ADL) Score

时间窗: Baseline to 3 months after treatment initiation

Physical function will be assessed by measuring changes in the Activities of Daily Living (ADL) score using the patient-reported portion of the CARG-GA. The primary objective is to determine if the GAIN-S intervention improves physical function compared to standard care.

次要结局

  • Change in Health-Related Quality of Life (FACT-G Score)(Baseline to 3 months after treatment initiation)
  • Change in Symptoms of Depression (Geriatric Depression Scale - GDS)(Baseline to 3 months after treatment initiation)
  • Change in Symptoms of Depression (Geriatric Depression Scale - GDS)(Baseline to 3 months after treatment initiation)
  • Change in Health-Related Quality of Life (FACT-G Score)(Baseline to 3 months after treatment initiation)

研究者

发起方
Cristiane Decat Bergerot, PhD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Cristiane Decat Bergerot, PhD

Head of Supportive Care

Instituto Oncoclinicas

研究点 (2)

Loading locations...

相似试验